Our study suggests and validates that CDK1 and CDC20 are potential therapeutic targets and prognostic biomarkers of LUSC.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: